Tesla
TSLA
Apple
AAPL
Meta Platforms
META
4
Intel
INTC
5
Microsoft
MSFT
US Stock MarketDetailed Quotes
VYGR Voyager Therapeutics
- 3.880
- 0.0000.00%
Close Mar 21 16:00 ET
- 3.880
- 0.0000.00%
Post 20:01 ET
214.20MMarket Cap-3.43P/E (TTM)
3.920High3.775Low428.04KVolume3.820Open3.880Pre Close1.65MTurnover0.95%Turnover RatioLossP/E (Static)55.21MShares10.66052wk High0.71P/B175.09MFloat Cap3.56052wk Low--Dividend TTM45.13MShs Float31.910Historical High--Div YieldTTM3.74%Amplitude2.460Historical Low3.850Avg Price1Lot Size
About Voyager Therapeutics Company
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Lexington, MA.
Company Profile
SymbolVYGR
Company NameVoyager Therapeutics
Listing DateNov 11, 2015
Issue Price14.00
Founded2013
CEODr. Alfred W. Sandrock, Jr,M.D.,PhD
MarketNASDAQ
Employees172
Fiscal Year Ends12-31
Address75 Hayden Avenue
CityLexington
ProvinceMassachusetts
CountryUnited States of America
Zip Code02421
Phone1-857-259-5340
Company Executives
- Name
- Position
- Salary
- Dr. Alfred W. Sandrock, Jr,M.D.,PhD
- Director, President and Chief Executive Officer
- 3.17M
- Robin Swartz
- Chief Operating Officer
- 1.38M
- Jacquelyn Fahey Sandell, J.D.
- Chief Legal Officer
- 1.68M
- Dr. Nathan Jorgensen, M.B.A.,PhD
- Chief Financial Officer and Principal Accounting Officer
- --
- Toby Ferguson
- Chief Medical Officer
- --
- Dr. Todd Carter, PhD
- Chief Scientific Officer
- --
- Michael J. Higgins
- Chairman of the Board
- 281.28K
- Dr. Jude Onyia, PhD
- Director
- 452.32K
- Dr. Steven E. Hyman, M.D.
- Independent Director
- 255.78K
- James A. Geraghty
- Independent Director
- 263.78K
- Dr. George A. Scangos,PhD
- Independent Director
- 559.79K
- Dr. Catherine J. Mackey, PhD
- Independent Director
- 250.78K
- Nancy Vitale
- Independent Director
- 255.28K
- Dr. Grace E. Colon, PhD
- Independent Director
- 432.23K
- Dr. Glenn F. Pierce, M.D.,PhD
- Independent Director
- 248.78K
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call